Estimate Recalculated Nov 1, 2024 10:48AM EST
Thomas Templeman has an estimated net worth of $2.75 Million. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Centessa Pharmaceuticals plc, and MEDIVATION, INC..
Thomas Templeman's CIK is 0001654274
2021 was Thomas Templeman's most active year for acquiring shares with 4 total transactions. Thomas Templeman's most active month to acquire stocks was the month of January. 2022 was Thomas Templeman's most active year for disposing of shares, totalling 4 transactions. Thomas Templeman's most active month to dispose stocks was the month of August. 2021 saw Thomas Templeman paying a total of $5,000.00 for 1,298,458 shares, this is the most they've acquired in one year. In 2022 Thomas Templeman cashed out on 12,761 shares for a total of $49,773.10, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!